Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A dose blocked-randomized, double-blind, placebo controlled, single and multiple dosing, dose-escalation phase I clinical trial to investigate the safety, tolerability, pharmacokinetic/pharmacodynamics characteristics and food effect of HSG4112 after oral administration in healthy and obese male subjects

Trial Profile

A dose blocked-randomized, double-blind, placebo controlled, single and multiple dosing, dose-escalation phase I clinical trial to investigate the safety, tolerability, pharmacokinetic/pharmacodynamics characteristics and food effect of HSG4112 after oral administration in healthy and obese male subjects

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 23 Sep 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs HSG 4112 (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jun 2018 New trial record
    • 29 May 2018 According to a Glaceum Inc. media release, the Korean Ministry of Food and Drug Safety (MFDS) approved the IND for the initiation of clinical trials for HSG4112.
    • 28 May 2018 According to a Glaceum Inc. media release, the trial will be conducted at Seoul National University Hospital until the first quarter 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top